[HTML][HTML] Metformin-mediated epigenetic modifications in diabetes and associated conditions: biological and clinical relevance

R Giordo, AM Posadino, AA Mangoni… - Biochemical Pharmacology, 2023 - Elsevier
An intricate interplay between genetic and environmental factors contributes to the
development of type 2 diabetes (T2D) and its complications. Therefore, it is not surprising …

Structural basis of promiscuous substrate transport by Organic Cation Transporter 1

YC Zeng, M Sobti, A Quinn, NJ Smith… - Nature …, 2023 - nature.com
Abstract Organic Cation Transporter 1 (OCT1) plays a crucial role in hepatic metabolism by
mediating the uptake of a range of metabolites and drugs. Genetic variations can alter the …

[HTML][HTML] Promising use of metformin in treating neurological disorders: biomarker-guided therapies

A Loan, C Syal, M Lui, L He, J Wang - Neural Regeneration …, 2024 - journals.lww.com
Neurological disorders are a diverse group of conditions that affect the nervous system and
include neurodegenerative diseases (Alzheimer's disease, multiple sclerosis, Parkinson's …

Identification of Novel Intronic SNPs in Transporter Genes Associated with Metformin Side Effects

N Schweighofer, M Strasser, A Obermayer, O Trummer… - Genes, 2023 - mdpi.com
Metformin is a widely used and effective medication in type 2 diabetes (T2DM) as well as in
polycystic ovary syndrome (PCOS). Single nucleotide polymorphisms (SNPs) contribute to …

Obligatory role of AMPK activation and antioxidant defense pathway in the regulatory effects of metformin on cellular protection and prevention of lens opacity

B Chhunchha, E Kubo, DP Singh - Cells, 2022 - mdpi.com
Increasing levels of oxidative-stress due to deterioration of the Nrf2 (NFE2-related
factor)/ARE (antioxidant response element) pathway is found to be a primary cause of aging …

The development and benefits of metformin in various diseases

Y Dong, Y Qi, H Jiang, T Mi, Y Zhang, C Peng, W Li… - Frontiers of …, 2023 - Springer
Metformin has been used for the treatment of type II diabetes mellitus for decades due to its
safety, low cost, and outstanding hypoglycemic effect clinically. The mechanisms underlying …

[HTML][HTML] Metabolic basis of solute carrier transporters in treatment of type 2 diabetes mellitus

J Le, Y Chen, W Yang, L Chen, J Ye - Acta Pharmaceutica Sinica B, 2024 - Elsevier
Solute carriers (SLCs) constitute the largest superfamily of membrane transporter proteins.
These transporters, present in various SLC families, play a vital role in energy metabolism …

Influence of Solute Carrier Family 22 Member 1 (SLC22A1) Gene Polymorphism on Metformin Pharmacokinetics and HbA1c Levels: A Systematic Review

AD Pradana, E Kristin… - Current Diabetes …, 2024 - benthamdirect.com
Background: Solute Carrier Family 22 Member 1 (SLC22A1, also known as OCT1) protein
has a vital role in the metabolism of metformin, a first-line anti-diabetes medication. Genetic …

Inhibitory effects of flavonoids on organic cation transporter 1: Implications for food/herb-drug interactions and hepatoprotective effects

W Bai, H Tan, X Duan, J Hu, F Wang, J Wu… - Food and Chemical …, 2024 - Elsevier
Abstract Organic cation transporter 1 (OCT1, gene symbol: SLC22A1) is mainly responsible
for the hepatic uptake of various cationic drugs, closely associated with drug-induced liver …

Metformin-suppressed platelet's function in vitro: Possible relation to delayed or failure of platelet-rich fibrin preparation

T Uematsu, H Masuki, M Nakamura, H Kawabata… - Toxicology in Vitro, 2023 - Elsevier
Platelet-rich fibrin (PRF) is a popular autologous blood-derived biomaterial that is used in
regenerative therapy. Owing to its simple preparation without additional factors, the PRF …